China Unveils Groundbreaking Policy for Innovative Drugs: What the New Commercial Insurance Catalog Means for Investors & FoundersChina Finance Tech in ChinaChina healthcare, commercial insurance, drug policy, Hotgen Biotech, pharmaceutical innovation, RemeGen, Shatshn July 1, 2025
China Unveils a Game-Changing Policy for Innovative Drugs: Here’s What Investors Need to KnowChina Finance Tech in ChinaBiotech, Healthcare, Hotgen Biotech, Pharmaceuticals, policy, RemeGen, Shutaishen, Sino Biopharmaceutical, Yifan Pharmaceutical July 1, 2025
